392 related articles for article (PubMed ID: 15674101)
1. Telomerase, hTERT and splice variants in Barrett's oesophagus and oesophageal adenocarcinoma.
Barclay JY; Morris A; Nwokolo CU
Eur J Gastroenterol Hepatol; 2005 Feb; 17(2):221-7. PubMed ID: 15674101
[TBL] [Abstract][Full Text] [Related]
2. Telomerase reverse transcriptase expression is increased early in the Barrett's metaplasia, dysplasia, adenocarcinoma sequence.
Lord RV; Salonga D; Danenberg KD; Peters JH; DeMeester TR; Park JM; Johansson J; Skinner KA; Chandrasoma P; DeMeester SR; Bremner CG; Tsai PI; Danenberg PV
J Gastrointest Surg; 2000; 4(2):135-42. PubMed ID: 10675236
[TBL] [Abstract][Full Text] [Related]
3. HTERT mRNA partially regulates telomerase activity in gastric adenocarcinoma and adjacent normal gastric mucosa.
Barclay JY; Morris AG; Nwokolo CU
Dig Dis Sci; 2005 Jul; 50(7):1299-303. PubMed ID: 16047476
[TBL] [Abstract][Full Text] [Related]
4. DNA hypermethylation regulates the expression of members of the Mu-class glutathione S-transferases and glutathione peroxidases in Barrett's adenocarcinoma.
Peng DF; Razvi M; Chen H; Washington K; Roessner A; Schneider-Stock R; El-Rifai W
Gut; 2009 Jan; 58(1):5-15. PubMed ID: 18664505
[TBL] [Abstract][Full Text] [Related]
5. Cyclooxygenase-2 is expressed frequently and early in Barrett's oesophagus and associated adenocarcinoma.
Lagorce C; Paraf F; Vidaud D; Couvelard A; Wendum D; Martin A; Fléjou JF
Histopathology; 2003 May; 42(5):457-65. PubMed ID: 12713622
[TBL] [Abstract][Full Text] [Related]
6. Activation of Akt is increased in the dysplasia-carcinoma sequence in Barrett's oesophagus and contributes to increased proliferation and inhibition of apoptosis: a histopathological and functional study.
Beales IL; Ogunwobi O; Cameron E; El-Amin K; Mutungi G; Wilkinson M
BMC Cancer; 2007 Jun; 7():97. PubMed ID: 17559672
[TBL] [Abstract][Full Text] [Related]
7. [Changes of alternative splicing variants of human telomerase reverse transcriptase during gastric carcinogenesis].
Xu JH; Wang YC; Geng X; Zhang WM
Ai Zheng; 2008 Dec; 27(12):1271-6. PubMed ID: 19079992
[TBL] [Abstract][Full Text] [Related]
8. Alteration of glutathione S-transferase levels in Barrett's metaplasia compared to normal oesophageal epithelium.
Cobbe SC; Scobie GC; Pohler E; Hayes JD; Kernohan NM; Dillon JF
Eur J Gastroenterol Hepatol; 2003 Jan; 15(1):41-7. PubMed ID: 12544693
[TBL] [Abstract][Full Text] [Related]
9. Sucrase-isomaltase gene expression in Barrett's esophagus and adenocarcinoma.
Wu GD; Beer DG; Moore JH; Orringer MB; Appelman HD; Traber PG
Gastroenterology; 1993 Sep; 105(3):837-44. PubMed ID: 8359653
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA profiling of Barrett's oesophagus and oesophageal adenocarcinoma.
Wijnhoven BP; Hussey DJ; Watson DI; Tsykin A; Smith CM; Michael MZ;
Br J Surg; 2010 Jun; 97(6):853-61. PubMed ID: 20301167
[TBL] [Abstract][Full Text] [Related]
11. In situ hybridization for the detection of telomerase RNA in the progression from Barrett's esophagus to esophageal adenocarcinoma.
Morales CP; Lee EL; Shay JW
Cancer; 1998 Aug; 83(4):652-9. PubMed ID: 9708927
[TBL] [Abstract][Full Text] [Related]
12. Preferential up-regulation of heparanase and cyclooxygenase-2 in carcinogenesis of Barrett's oesophagus and intestinal-type gastric carcinoma.
Sonoda R; Naomoto Y; Shirakawa Y; Fujiwara Y; Yamatsuji T; Noma K; Tanabe S; Takaoka M; Gunduz M; Tsujigiwa H; Nagatsuka H; Ohara N; Yoshino T; Takubo K; Vieth M; Tanaka N
Histopathology; 2010 Jul; 57(1):90-100. PubMed ID: 20653782
[TBL] [Abstract][Full Text] [Related]
13. Fatty acid synthase expression in Barrett's esophagus: implications for carcinogenesis.
Ishimura N; Amano Y; Sanchez-Siles AA; Fukuhara H; Takahashi Y; Uno G; Tamagawa Y; Mishima Y; Yuki T; Ishihara S; Kinoshita Y
J Clin Gastroenterol; 2011 Sep; 45(8):665-72. PubMed ID: 21325951
[TBL] [Abstract][Full Text] [Related]
14. Increased CDX2 and decreased PITX1 homeobox gene expression in Barrett's esophagus and Barrett's-associated adenocarcinoma.
Lord RV; Brabender J; Wickramasinghe K; DeMeester SR; Holscher A; Schneider PM; Danenberg PV; DeMeester TR
Surgery; 2005 Nov; 138(5):924-31. PubMed ID: 16291394
[TBL] [Abstract][Full Text] [Related]
15. Telomerase activity and expression of telomerase genes in squamous dysplasia and squamous cell carcinoma of the esophagus.
Yu HP; Xu SQ; Lu WH; Li YY; Li F; Wang XL; Su YH
J Surg Oncol; 2004 May; 86(2):99-104. PubMed ID: 15112252
[TBL] [Abstract][Full Text] [Related]
16. Modelling Barrett's oesophagus.
Kong J; Stairs DB; Lynch JP
Biochem Soc Trans; 2010 Apr; 38(2):321-6. PubMed ID: 20298176
[TBL] [Abstract][Full Text] [Related]
17. Differential SPARC mRNA expression in Barrett's oesophagus.
Brabender J; Lord RV; Metzger R; Park J; Salonga D; Danenberg KD; Danenberg PV; Hölscher AH; Schneider PM
Br J Cancer; 2003 Oct; 89(8):1508-12. PubMed ID: 14562024
[TBL] [Abstract][Full Text] [Related]
18. Glutathione S-transferase-pi expression is downregulated in patients with Barrett's esophagus and esophageal adenocarcinoma.
Brabender J; Lord RV; Wickramasinghe K; Metzger R; Schneider PM; Park JM; Hölscher AH; DeMeester TR; Danenberg KD; Danenberg PV
J Gastrointest Surg; 2002; 6(3):359-67. PubMed ID: 12022988
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of fatty acid synthase expression in oesophageal mucosa of patients with oesophagitis, Barrett's oesophagus and adenocarcinoma.
Crispino P; Alò PL; Rivera M; Barillà D; Nardi F; Mariotti M; Giancarlo Z; Botti C; Pica R; Cassieri C; Unim H; Paoluzi P
J Cancer Res Clin Oncol; 2009 Nov; 135(11):1533-41. PubMed ID: 19471962
[TBL] [Abstract][Full Text] [Related]
20. IGFBP-3 and IGFBP-10 (CYR61) up-regulation during the development of Barrett's oesophagus and associated oesophageal adenocarcinoma: potential biomarkers of disease risk.
Di Martino E; Wild CP; Rotimi O; Darnton JS; Olliver RJ; Hardie LJ
Biomarkers; 2006; 11(6):547-61. PubMed ID: 17056474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]